Welcome to our dedicated page for Multiplan Corporation SEC filings (Ticker: MPLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning MultiPlan’s disclosures for shifts in claims volume or payer contracts can feel like hunting for needles across hundreds of pages. Healthcare cost-management revenue hinges on nuanced reimbursement formulas, so the 10-K and 10-Q narratives are unusually dense. If you’ve ever wondered “how do I track MultiPlan insider trading Form 4 transactions before the market reacts?” or “where is the MultiPlan quarterly earnings report 10-Q filing explained in plain English?”, this page was built for you.
Stock Titan’s AI breaks down every document the moment it hits EDGAR. Receive real-time alerts on MultiPlan Form 4 insider transactions, get a streamlined view of cash-flow changes from the latest 10-Q, and read MultiPlan SEC filings explained simply—no accounting degree required. Our platform links key disclosures to what matters most in cost containment: client concentration tables, network pricing methodologies, and regulatory risk updates. You’ll also find side-by-side comparisons of prior periods, letting you perform a quick MultiPlan earnings report filing analysis without scrolling through footnotes.
Dive deeper when material news breaks: we tag every MultiPlan 8-K material events explained, highlight compensation shifts in the MultiPlan proxy statement executive compensation, and flag unusual activity through MultiPlan executive stock transactions Form 4. Need the bigger picture? Access the MultiPlan annual report 10-K simplified for long-term trends or use our AI guide for understanding MultiPlan SEC documents with AI. From segment revenue swings to contract renewal clauses, Stock Titan surfaces the insights analysts discuss—so you can act with confidence.
White Dale A., a director of Claritev Corp (CTEV), reported transactions dated 08/21/2025 that moved 201,652 shares of Class A common stock from direct ownership into a revocable trust. The Form 4 shows a Code G transfer with a reported price of $0, indicating an internal transfer rather than a market sale. After the transfer the reporting person is shown with 160,080 shares held directly and 201,652 shares held indirectly by trust. The filing is signed by an attorney-in-fact on 08/25/2025.
Claritev Corp (CTEV) reporting person Dalton Travis, who is President, CEO & Executive Chair and a director, reported purchases of Class A common stock totaling 4,282 shares. The Form 4 shows a purchase of 300 shares on 08/08/2025 at a weighted average price of $54.2083 (individual trades ranged $54.18–$54.25) and a purchase of 3,982 shares on 08/11/2025 at a weighted average price of $58.3019 (individual trades ranged $58.06–$58.50). The shares are reported as indirectly beneficially owned in the reporting person’s spouse’s Individual Retirement Account, bringing indirect holdings to 4,282 shares. The Form 4 was executed by attorney-in-fact Kent Bartholomew and dated 08/12/2025.
Claritev Corporation reported that its Executive Vice President and Chief Operating Officer, Jerome Hogge, purchased 5,621 shares of Class A common stock on 08/07/2025 at a weighted average price of $53.5084 (individual trades ranged from $53.26 to $53.56). Following these purchases, Hogge's beneficial ownership increased to 90,023 shares.
The Form 4 notes the price shown is a weighted average for multiple transactions and that the reporting person will provide full breakdowns of the number of shares purchased at each price upon request. No derivative transactions are reported on this form.
FAQ
What is the current stock price of Multiplan Corporation (MPLN)?
What is the market cap of Multiplan Corporation (MPLN)?
